Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial revascularization surgery (CABG), especially when ejection fraction is ≤35%. 

Asistencia ventricular en anatomías complejas y deterioro severo de la función ventricular izquierda

However, CABG is not always a viable choice, because of multiple comorbidities, which makes percutaneous coronary intervention (PCI) a valid alternative. In this scenario, chronic total occlusion (CTO) is frequent, which increases the risk of complications and ischemia during procedure, be it anterograde or retrograde, compromising also donated vessels. Even though still controversial, in these cases, using mechanical circulatory support devices can be the right strategy. 

27 severe CAD patients were analyzed; there was at least one CTO and severe left ventricular dysfunction. 

Primary end point was MACE, a composite of cardiovascular death, MI and target lesion revascularization (TLR) at 90 days.  

Mean patient age was 63, and 25 were men. Mean EuroSCORE was 5.07. As regards comorbidities, 11 were diabetic, 19 hypertensive, 19 had cardiac failure, 7 prior PCI, 4 prior CABG, 2 prior stroke, 3 had atrial fibrillation, 9 had peripheral vascular disease and 7 had kidney function deterioration. Mean ejection fraction was 23 ± 7%. 

Read also: Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation.

SYNTAX score was 37. In total, 38 CTO were treated; 14 patients presented three-vessel disease, and 11 two-vessel. The most frequent CTO was to the right coronary, followed by the anterior descending (AD) and, in lower proportion, the circumflex (CX). Mean J-CTO score was 2, with estimated MACE risk 2.5%. 

Impella Access site was transfemoral for 23 patients, 3 were transaxillary procedures and 1 transcarotid. Complete revascularization was achieved in 15 patients (56%).

At hospital level, one patients died of pericardial effusion, another had an MI and 3 had vascular complications.

Read also: TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

At 90 days, the primary outcome was seen in 3 patients: two deaths and 1 TLR. However, 22 patients experienced significant improvement of angina and dyspnea. Also there was a significant increase in ejection fraction, up to 33%, with a relevant reduction of systolic and diastolic volume. 

Conclusion

In high risk patients with severe ventricular function deterioration and complex anatomy, including CTO, PCI with mechanical circulatory support with Impella was associated with a favorable evolution in terms of safety and efficacy at short term. 

Original Title: Mechanical Circulatory Support With Impella in High‐Risk Patients With Chronic Total Occlusion and Complex Multivessel Disease. 

Reference: Ignacio Gallo, et al. Catheterization and Cardiovascular Interventions, 2025; 105:883–890 883 of 980 https://doi.org/10.1002/ccd.3139.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

Más artículos de este Autor

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas Guatemala 2026
Jornadas SOLACIspot_img

Artículos recientes

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...